Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Calithera Biosci Com (CALA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 298,032
  • Shares Outstanding, K 35,480
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,000 K
  • 36-Month Beta 2.88
  • Price/Sales 15.94
  • Price/Cash Flow N/A
  • Price/Book 1.87

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.90 +6.96%
on 01/16/18
9.15 -7.65%
on 01/02/18
unch (unch)
since 12/22/17
3-Month
7.65 +10.46%
on 12/18/17
17.95 -52.92%
on 11/02/17
-8.00 (-48.63%)
since 10/20/17
52-Week
4.25 +98.82%
on 01/23/17
20.05 -57.86%
on 07/13/17
+4.20 (+98.82%)
since 01/20/17

Most Recent Stories

More News
Technical Perspectives on Cytokinetics, Geron, Achillion Pharma, and Calithera Biosciences

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on CYTK, GERN, ACHN, and CALA which can be accessed for free by signing up to www.wallstequities.com/registration....

CYTK : 9.45 (-1.56%)
ACHN : 2.89 (-3.34%)
GERN : 1.93 (+0.52%)
CALA : 8.45 (+0.60%)
The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics

The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics

SGMO : 19.60 (+10.42%)
SRPT : 64.78 (+3.85%)
AKBA : 14.89 (+1.22%)
CALA : 8.45 (+0.60%)
GLYC : 23.75 (+0.68%)
5 Top-Ranked Drug Stocks that are Broker Favorites

With the pharma and biotech sector bouncing back in 2017, here is a look at five drug stocks including Sarepta (SRPT) that are broker favorites.

SGMO : 19.60 (+10.42%)
SRPT : 64.78 (+3.85%)
AKBA : 14.89 (+1.22%)
INCY : 94.30 (+1.22%)
CALA : 8.45 (+0.60%)
PFE : 36.99 (+0.14%)
GLYC : 23.75 (+0.68%)
Updated Results from Phase I Study of CB-839 in Combination with Paclitaxel in Patients with Triple Negative Breast Cancer to be Presented at the 2017 San Antonio Breast Cancer Symposium

Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology...

CALA : 8.45 (+0.60%)
S&P 500 Tops $2600: ETFs & Stocks That Deserve Special Thanks

Insights into the bunch of ETFs & stocks deserve special thanks.

ESIO : 26.88 (+1.66%)
ITB : 45.95 (-0.24%)
PXLG : 48.58 (+0.35%)
PSI : 55.06 (-0.13%)
MU : 42.42 (-0.77%)
KRO : 28.24 (-0.95%)
IGV : 167.39 (+0.24%)
FXL : 55.94 (-0.23%)
CALA : 8.45 (+0.60%)
TRTN : 37.94 (-0.78%)
Breakfast Technical Briefing on Biotech Stocks -- Calithera Biosciences, Celldex Therapeutics, Clovis Oncology, and Cytokinetics

If you want a Stock Review on CALA, CLDX, CLVS, or CYTK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Pre-market, DailyStockTracker.com dedicates...

CLDX : 2.77 (+0.36%)
CYTK : 9.45 (-1.56%)
CLVS : 59.17 (+4.25%)
CALA : 8.45 (+0.60%)
S&P 500 Tops $2600: ETFs & Stocks That Deserve Special Thanks

Insights into the bunch of ETFs & stocks deserve special thanks.

ESIO : 26.88 (+1.66%)
ITB : 45.95 (-0.24%)
PXLG : 48.58 (+0.35%)
PSI : 55.06 (-0.13%)
MU : 42.42 (-0.77%)
KRO : 28.24 (-0.95%)
IGV : 167.39 (+0.24%)
FXL : 55.94 (-0.23%)
CALA : 8.45 (+0.60%)
TRTN : 37.94 (-0.78%)
Initial Results from Phase 2 Study of CB-839 in Combination with Opdivo(R) (nivolumab) to be Presented at the Society for Immunotherapy of Cancer Meeting

Achieved confirmed responses in melanoma patients progressing on PD-1/PD-L1 therapy

CALA : 8.45 (+0.60%)
BMY : 63.08 (+1.28%)
Calithera Biosciences, Q3 Analysis, Analysts Target and Clinical Trials Review

NEW YORK, NY / ACCESSWIRE / November 6, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

CALA : 8.45 (+0.60%)
Calithera Biosciences Reports Third Quarter 2017 Financial Results and Recent Highlights

Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology...

CALA : 8.45 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. It is focused on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The Company's lead product candidate includes CB-839 which is in three Phase...

See More

Key Turning Points

2nd Resistance Point 8.83
1st Resistance Point 8.62
Last Price 8.45
1st Support Level 8.07
2nd Support Level 7.73

See More

52-Week High 20.05
Fibonacci 61.8% 14.01
Fibonacci 50% 12.15
Fibonacci 38.2% 10.29
Last Price 8.45
52-Week Low 4.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.